{"url_path":"/sec/sgp/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1778922/0001778922-26-000035-index.html","accession_number":"0001778922-26-000035","cik":"0001778922","ticker":"SGP","issuer_name":"SpyGlass Pharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1778922/0001778922-26-000035-index.html","primary_entity_key":"0001778922","primary_entity_name":"SpyGlass Pharma, Inc."},"word_count":30,"has_tables":true,"body_markdown":"Item 1. Legal Proceedings\n\nThe information required by Item 103 of Regulation S-K is included in “Part I - Item 1. Financial Statements - Note 7 - Commitments and Contingencies.”"}